AbbVie Inc.

ABBV•NYSE•Healthcare

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for th...

Source: FMP Company Profile•View Source

Filing Change Timeline

No Analysis Available Yet

We haven't analyzed AbbVie Inc.'s SEC filings yet.

Request Analysis

Official SEC Filings

View all SEC EDGAR filings for ABBV

sec.gov

Disclaimer: Fysight provides AI-generated analysis of SEC filings for informational purposes only. This is not financial advice. We do not provide buy, sell, or hold recommendations. All analysis is based on publicly available SEC filings and should not be used as the sole basis for investment decisions. Always consult a qualified financial advisor.